Anti-arrhythmic actions of  -adrenergic receptor antagonists: review of fundamental aspects.
D000200:Action Potentials / Q000187:drug effects; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D004071:Digitalis Glycosides / Q000009:adverse effects; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D009203:Myocardial Infarction / Q000150:complications; D011433:Propranolol / Q000494:pharmacology; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D013015:Sotalol / Q000008:administration & dosage / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D007211:Indoles; D011433:Propranolol; D013015:Sotalol